Summary
- Profile Type
- Business Offer
- POD Reference
- BOPL20240731004
- Term of Validity
- 6 August 2024 - 6 August 2025
- Company's Country
- Poland
- Type of partnership
- Commercial agreement
- Investment agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- A Polish company develops microfluidic filtration systems for sustainable biomanufacturing, validated on a 10,000-liter bioreactor. Specializing in algae and cultivated meat, they aim to expand into biopharmaceuticals. Seeking international partners to advance their technology and tap into emerging markets.
- Full Description
-
The Polish company specializes in developing microfluidics-based filtration systems for sustainable biomanufacturing processes. The core technology leverages microfluidics to enable more efficient and gentle processing of biomass, making it suitable for a variety of microorganisms, including microalgae, yeast, and bacteria.
The company has successfully validated its technology on a 10,000-liter bioreactor, marking a significant milestone in the scalability and commercial viability of its innovative microfluidic filtration system. This large-scale validation demonstrates the robustness and efficiency of the technology, which has been shown to provide substantial energy savings and improved yields in the processing of microbial cell cultures. - Advantages and Innovations
-
The Polish company is revolutionizing bioproduction with its innovative continuous manufacturing technology, significantly enhancing bio-producer's yield (up to 10x) and cost-efficiency for cell-based production. Its advanced microfluidics-based filtration systems offer superior throughput, scalability, and sustainability compared to conventional methods such as batch processing and tangential flow filtration (TFF).
This technology enables increased productivity by converting existing bioreactor capacity to run in a continuous perfusion culture process, validated at lab scale with ongoing trials for commercial-scale validation. The system is easily retrofitted, reducing capital expenditures and operational expenses through efficiency gains in cleaning, consumables, and cell seeding.
Key advantages include fully scalable stainless-steel filters that can be cleaned and sterilized in place. The microfluidic systems do not damage cells, feature high permeability, and do not clog, making them ideal for perfusion systems or biomass with high viscosity. This innovation addresses critical industry challenges of scalability, sustainability, and cost-efficiency, potentially revolutionizing - Stage of Development
- Available for demonstration
- Sustainable Development Goals
- Goal 17: Partnerships to achieve the Goal
- Goal 9: Industry, Innovation and Infrastructure
- Goal 2: Zero Hunger
- Goal 13: Climate Action
- Goal 12: Responsible Consumption and Production
- Goal 6: Clean Water and Sanitation
- IPR status
- IPR granted
Partner Sought
- Expected Role of a Partner
-
The Polish company is seeking partnerships with entities across various sectors to advance its innovative microfluidics-based filtration systems.
Bio-producers and early adopters: Expected to integrate and validate the technology within their production processes, especially in microalgae-based bioproduction and alternative protein production such as cultivated meat. These partners will provide practical feedback and data to optimize performance, ensuring the technology meets industry needs. By leveraging the innovative microfluidics-based filtration systems, these producers can achieve higher yields and cost-efficiency, significantly enhancing their biomanufacturing operations. This collaboration will facilitate the development of sustainable bioproduction practices and contribute to the advancement of alternative protein sources.
Research institutions: To collaborate on further studies and advancements, leveraging academic expertise to refine and enhance the technology.
Investors: To provide financial support for scaling operations, expanding market reach, and accelerating research and development efforts.
Corporations specializing in bioprocessing equipment: To engage in joint development projects, focusing on the integration and commercialization of the filtration systems, ensuring they meet industry standards and customer needs.
Corporations in the biopharmaceutical industry: To utilize the technology in their production processes, enhancing efficiency and sustainability, and contributing to the development and market readiness of advanced bioprocessing solutions. - Type and Size of Partner
- Big company
- SME 50 - 249
- SME 11-49
- University
- SME <=10
- R&D Institution
- Type of partnership
- Commercial agreement
- Investment agreement
Dissemination
- Technology keywords
- 06006012 - Bioprocesses
- 02007020 - Biobased materials
- 06006005 - Biobased high-performance materials
- Market keywords
- 08001015 - Other speciality materials
- 09004008 - Other manufacturing (not elsewhere classified)
- Targeted countries
- All countries